Tenet Healthcare Co. (NYSE:THC – Get Free Report) Director Richard W. Fisher sold 836 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $173.16, for a total transaction of $144,761.76. Following the transaction, the director now directly owns 11,292 shares in the company, valued at approximately $1,955,322.72. This trade represents a 6.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Tenet Healthcare Stock Down 0.3%
Tenet Healthcare stock opened at $171.36 on Friday. The company has a 50-day simple moving average of $144.43 and a 200-day simple moving average of $137.09. The firm has a market capitalization of $15.92 billion, a P/E ratio of 5.32, a P/E/G ratio of 1.02 and a beta of 1.65. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare Co. has a one year low of $109.82 and a one year high of $174.14.
Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, topping the consensus estimate of $3.11 by $1.25. The business had revenue of $5.22 billion during the quarter, compared to analyst estimates of $5.15 billion. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The company’s quarterly revenue was down 2.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.22 earnings per share. As a group, equities analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.
Hedge Funds Weigh In On Tenet Healthcare
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. Bank of America boosted their target price on shares of Tenet Healthcare from $165.00 to $180.00 and gave the stock a “buy” rating in a research report on Wednesday, May 14th. TD Cowen assumed coverage on shares of Tenet Healthcare in a research report on Wednesday, February 26th. They set a “buy” rating and a $175.00 target price on the stock. Stephens raised shares of Tenet Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Guggenheim started coverage on shares of Tenet Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $165.00 target price on the stock. Finally, Robert W. Baird reaffirmed a “neutral” rating and issued a $137.00 price target (down from $153.00) on shares of Tenet Healthcare in a report on Tuesday, April 15th. Four analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $180.18.
Check Out Our Latest Stock Report on THC
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Read More
- Five stocks we like better than Tenet Healthcare
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 06/02 – 06/06
- 3 Monster Growth Stocks to Buy Now
- A Large Oil Supply Draw Could Mean Upside in These 3 Energy Names
- Why Are These Companies Considered Blue Chips?
- 3 Stocks Getting Rare Double Upgrades From Analysts
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.